argenx SE
broadened scope of safety | argenx SE
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
9 of 23
Similar slides by argenx SE
See diffirences between slides (animation)
Investor Conference
January 2023
broadened scope of safety | argenx SE
Related slides by other companies
Kymera
Investor Presentation
August 2023
part summary | Kymera
23andMe
Investor Presentation
January 2024
next steps | 23andMe
Erasca
Investor Presentation
November 2023
has been dosed in more than patients to date establishing its safety tolerability and preliminary in multiple indications | Erasca
Recursion Pharmaceuticals
Investor Day
January 2023
clinical well understood clinical safety with a drug like profile further confidence prior studies suggestive of potential therapeutic benefit | Recursion Pharmaceuticals
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io